Meta Pixel

Minor Cannabinoids: CBN, CBG, THCV & Their Benefits

Minor Cannabinoids: CBN, CBG, THCV & Their Benefits


Beyond THC and CBD, the cannabis plant produces over 100 other cannabinoids — collectively known as minor cannabinoids. These compounds are gaining significant attention as researchers discover their unique therapeutic properties and as product manufacturers find ways to isolate and concentrate them. From CBN for sleep to THCV for energy, minor cannabinoids are expanding what cannabis can do.

CBN (Cannabinol): The Sleepy Cannabinoid

CBN is formed when THC ages and oxidizes — it's literally old THC. While it was once considered a degradation byproduct, CBN has emerged as one of the most sought-after minor cannabinoids, primarily for its reputed sedative effects.

  • Primary use: Sleep aid and relaxation. CBN is marketed as a natural alternative to melatonin and prescription sleep medications.
  • Effects: Mildly psychoactive (about 10% the potency of THC). Produces gentle sedation without a strong high.
  • Research status: Limited but promising. A landmark 1975 study suggested CBN enhanced the sedative effects of THC, but more rigorous human trials are needed.
  • Products: CBN gummies, tinctures, capsules, and sleep-specific formulations, often combined with CBD and melatonin.

CBG (Cannabigerol): The Mother Cannabinoid

CBG is called the "mother cannabinoid" because its acidic form (CBGA) is the precursor from which all other cannabinoids are synthesized. Young cannabis plants contain high levels of CBGA, which enzymes convert into THCA, CBDA, and CBCA as the plant matures. By harvest, most CBG has been converted, leaving only 1% or less in the final flower.

  • Primary use: Anti-inflammatory and pain relief. CBG interacts with both CB1 and CB2 receptors, giving it a broader receptor profile than CBD.
  • Effects: Non-psychoactive. Users report subtle mood elevation, focus enhancement, and physical relaxation without any high.
  • Research status: Studies have shown potential for inflammatory bowel disease, glaucoma (reducing intraocular pressure), bladder dysfunction, and antibacterial activity against MRSA.
  • Products: CBG oil, tinctures, capsules, and increasingly in flower form from specially bred high-CBG cultivars.

THCV (Tetrahydrocannabivarin): The Sports Car

THCV is one of the most intriguing minor cannabinoids. Structurally similar to THC but with a shorter carbon chain, THCV produces notably different effects and has earned the nickname "diet weed" and "the sports car of cannabinoids" for its energetic, clear-headed profile.

  • Primary use: Energy, focus, and appetite suppression. Unlike THC, which famously stimulates appetite (the munchies), THCV may actually reduce it.
  • Effects: At low doses, THCV blocks CB1 receptors (like CBD). At higher doses, it activates them, producing a short-lived, clear, energetic high that lasts about half as long as a THC high.
  • Research status: Studies suggest potential for weight management, diabetes (improving insulin sensitivity), anxiety reduction (without sedation), and bone growth stimulation.
  • Products: THCV is rare and expensive to isolate. Found in specialty tinctures, gummies, and in African landrace strains like Durban Poison.

CBC (Cannabichromene): The Pain Fighter

CBC is the third most abundant cannabinoid in many cannabis strains, though it remains far less studied than THC or CBD. It doesn't bind strongly to CB1 or CB2 receptors but interacts with other receptors involved in pain perception, including TRPV1 and TRPA1 (vanilloid receptors).

  • Primary use: Pain management and anti-inflammation, potentially working synergistically with THC and CBD through the entourage effect.
  • Effects: Non-psychoactive. May enhance the pain-relieving effects of other cannabinoids when consumed together.
  • Research status: Studies suggest antidepressant potential, neuroprotective properties, and acne-fighting capabilities through sebum regulation.
  • Products: Rarely sold in isolation; most commonly found in full-spectrum products that preserve the complete cannabinoid profile.

Delta-8 THC and Delta-10 THC

Delta-8 and delta-10 THC are isomers of the more common delta-9 THC. They share the same chemical formula but differ in the position of a double bond in the carbon chain. These subtle structural differences produce noticeably different effects.

Delta-8 THC

Delta-8 produces a milder high than delta-9, often described as "THC lite." Users report less anxiety, less paranoia, and a clearer head. It's about 50-75% as potent as delta-9 THC. Delta-8 gained massive popularity through the hemp loophole, as it can be synthesized from CBD extracted from legal hemp. However, many states have moved to ban or regulate it.

Delta-10 THC

Delta-10 is even milder than delta-8 and is associated with uplifting, sativa-like effects. Users describe it as energizing and focus-enhancing with minimal psychoactivity. Like delta-8, it's typically synthesized from hemp-derived CBD and faces increasing regulatory scrutiny.

Safety Note
Synthetically derived cannabinoids like delta-8 and delta-10 require chemical conversion processes that may produce unknown byproducts if not properly performed. Always buy from brands that provide full panel lab testing including tests for contaminants and byproducts.

Other Emerging Cannabinoids

HHC (Hexahydrocannabinol)

HHC is a hydrogenated form of THC — similar to how margarine is hydrogenated vegetable oil. It produces psychoactive effects comparable to delta-9 THC but with reportedly greater stability and a longer shelf life. HHC exists naturally in cannabis in trace amounts but is commercially produced through hydrogenation of THC or CBD.

CBDV (Cannabidivarin)

CBDV is a variant of CBD with a shorter carbon chain. Early research suggests it may be particularly effective for nausea, seizures, and autism spectrum disorder. GW Pharmaceuticals (makers of Epidiolex) has been studying CBDV for epilepsy treatment. Like CBD, CBDV is non-psychoactive.

How to Find Minor Cannabinoid Products

Minor cannabinoid products are increasingly available at dispensaries and through delivery services. Here's how to find them:

  • Read lab results: Full panel COAs will list all detected cannabinoids, including minors. Look for products with diverse cannabinoid profiles.
  • Choose full-spectrum: Full-spectrum products preserve the plant's natural cannabinoid diversity, including minor cannabinoids.
  • Look for isolate blends: Some brands create targeted formulations by blending cannabinoid isolates (e.g., CBD + CBN for sleep, CBD + CBG for inflammation).
  • Ask your budtender: Describe the effects you want, and they can guide you toward products with the right minor cannabinoid profile.
  • Browse products: Filter by cannabinoid type to find exactly what you need.